Tech Leaders’ Money in Biotech Reached Public Stocks First Through Acquisitions and Narratives: A Map of 94 Companies and a Review of U.S. and Korean Listed Companies
A Map of Biotech Investing: Where You Earn Only If the Drug Works, and Where You Earn Whichever Drug Works
What's Happening in US Biotech? A Beginner's Map of 8 Big Trends and Their Korean Connections (2026-08-20)
Samsung: Kiwoom's KRW 390k vs KB's KRW 600k, By the Numbers — 'Level' and 'Growth Rate' Don't Conflict (2026-07-08)
Six Korean Bio Stocks, Made Simple — 'The Catalyst Is Alive' and 'It's Cheap' Are Not the Same Thing (2026-06-11)
Samsung Electro-Mechanics — The Invisible Infrastructure of AI Silicon. MLCC (Power Stability), FC-BGA (Chip Substrate), and Camera Modules Dissected
Humanoid Compare — Robotis (Actuators, 2026E PSR 79×) vs. Rainbow Robotics (Samsung Affiliate, 2025 PSR 476×). Both Expensive, but Verifiability Differs
Korea Robot Component Compare — SPG (Reducers, PER 110×) vs. Halla Cast (Lightweight Structural Parts, PER 62×). Both Expensive — Which Carries Less Risk?
